Literature DB >> 27534525

Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.

Cristina Valero1, Laura Pardo1, Montserrat López1, Jacinto García1, Mercedes Camacho2, Miquel Quer1, Xavier León1,3.   

Abstract

BACKGROUND: The purpose of this study was to analyze the prognostic value of pretreatment count of peripheral neutrophils, lymphocytes, monocytes, and neutrophil-to-lymphocyte ratio (NLR) in patients with head and neck squamous cell carcinoma (HNSCC).
METHODS: Local, regional, and distant recurrence-free survival and disease-specific survival were analyzed according to the count of neutrophils, lymphocytes, monocytes, and NLR.
RESULTS: We observed a decrease in disease-specific survival as the quartile category of neutrophils, monocytes, and NLR increased. In the case of lymphocytes, patients in the lower quartile had lower disease-specific survival. Considering the disease-specific survival as the dependent variable, a recursive partitioning analysis classified the patients according to the neutrophil and monocyte counts.
CONCLUSION: High pretreatment count of peripheral neutrophils and/or monocytes was independently related with worse prognosis in patients with HNSCC. Classification based on pretreatment neutrophil and monocyte counts enabled the identification of different prognostic profiles.
© 2016 Wiley Periodicals, Inc. Head Neck 39: 219-226, 2017. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  head and neck squamous cell carcinoma; lymphocytes; monocytes; neutrophil-to-lymphocyte ratio; neutrophils

Mesh:

Substances:

Year:  2016        PMID: 27534525     DOI: 10.1002/hed.24561

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  37 in total

1.  Elevated peripheral inflammatory markers are related with the recurrence and canceration of vocal fold leukoplakia.

Authors:  Yi Fang; Yue Yang; Min Chen; Peijie He; Lei Cheng; Jian Chen; Haitao Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-31       Impact factor: 2.503

2.  Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.

Authors:  Bangrong Cao; Qifeng Wang; Huan Zhang; Guiquan Zhu; Jinyi Lang
Journal:  Oncoimmunology       Date:  2017-11-06       Impact factor: 8.110

3.  Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer.

Authors:  Cristina Valero; Daniella K Zanoni; Marlena R McGill; Ian Ganly; Luc G T Morris; Miquel Quer; Jatin P Shah; Richard J Wong; Xavier León; Snehal G Patel
Journal:  Cancer       Date:  2019-12-06       Impact factor: 6.860

4.  Young non-smokers with oral cancer: What are we missing and why?

Authors:  Cristina Valero; Avery Yuan; Daniella K Zanoni; Emily Lei; Snjezana Dogan; Jatin P Shah; Luc G T Morris; Richard J Wong; Aviram Mizrachi; Snehal G Patel; Ian Ganly
Journal:  Oral Oncol       Date:  2022-03-05       Impact factor: 5.337

5.  Predictors of distant metastases in sinonasal and skull base cancer patients treated with surgery.

Authors:  Cristina Valero; Dauren Adilbay; Conall W R Fitzgerald; Avery Yuan; Ximena Mimica; Piyush Gupta; Richard J Wong; Jatin P Shah; Snehal G Patel; Marc A Cohen; Ian Ganly
Journal:  Oral Oncol       Date:  2021-10-21       Impact factor: 5.337

6.  Prognostic Value of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Head and Neck Malignancies.

Authors:  Yanish Bhashkar Seetohul; Vishwambhar Singh; Rajiv Kumar Jain; Ashvanee Kumar Chaudhary
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-11-25

7.  Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer.

Authors:  Tristan Tham; Caitlin Olson; Michael Wotman; Sireesha Teegala; Julian Khaymovich; Josephine Coury; Peter Costantino
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-24       Impact factor: 2.503

8.  Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma.

Authors:  Ching Ying Lin; Hyunwoo Kwon; Guillermo O Rangel Rivera; Xue Li; Dongjun Chung; Zihai Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-26       Impact factor: 4.254

9.  Advanced Lung Cancer Inflammation Index is a Prognostic Factor of Patients with Small-Cell Lung Cancer Following Surgical Resection.

Authors:  Zhonghui Hu; Wenbo Wu; Ping Li; Xiaopeng Zhang; Hua Zhang; Huien Wang; Wenfei Xue; Zhiguo Chen; Qingtao Zhao; Guochen Duan
Journal:  Cancer Manag Res       Date:  2021-02-26       Impact factor: 3.989

10.  Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study.

Authors:  Piergiorgio Gaudioso; Daniele Borsetto; Giancarlo Tirelli; Margherita Tofanelli; Fiordaliso Cragnolini; Anna Menegaldo; Cristoforo Fabbris; Gabriele Molteni; Daniele Marchioni; Piero Nicolai; Paolo Bossi; Andrea Ciorba; Stefano Pelucchi; Chiara Bianchini; Simone Mauramati; Marco Benazzo; Vittorio Giacomarra; Roberto Di Carlo; Mantegh Sethi; Jerry Polesel; Jonathan Fussey; Paolo Boscolo-Rizzo
Journal:  Support Care Cancer       Date:  2021-01-29       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.